|
Fusion gene ID: 14331 |
FusionGeneSummary for GALNT3_TTC21B |
Fusion gene summary |
Fusion gene information | Fusion gene name: GALNT3_TTC21B | Fusion gene ID: 14331 | Hgene | Tgene | Gene symbol | GALNT3 | TTC21B | Gene ID | 2591 | 79809 |
Gene name | polypeptide N-acetylgalactosaminyltransferase 3 | tetratricopeptide repeat domain 21B | |
Synonyms | GalNAc-T3|HFTC|HHS | ATD4|IFT139|IFT139B|JBTS11|NPHP12|Nbla10696|SRTD4|THM1 | |
Cytomap | 2q24.3 | 2q24.3 | |
Type of gene | protein-coding | protein-coding | |
Description | polypeptide N-acetylgalactosaminyltransferase 3GalNAc transferase 3UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3)polypeptide GalNAc transferase 3 | tetratricopeptide repeat protein 21BTPR repeat protein 21Bintraflagellar transport 139 homologputative protein product of Nbla10696 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q14435 | Q7Z4L5 | |
Ensembl transtripts involved in fusion gene | ENST00000392701, ENST00000409882, | ENST00000489714, ENST00000536175, ENST00000243344, | |
Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 1 X 1 X 1=1 |
# samples | 2 | 1 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(1/1*10)=3.32192809488736 | |
Context | PubMed: GALNT3 [Title/Abstract] AND TTC21B [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | GALNT3 | GO:0018242 | protein O-linked glycosylation via serine | 9295285 |
Hgene | GALNT3 | GO:0018243 | protein O-linked glycosylation via threonine | 9295285|16638743 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | PRAD | TCGA-V1-A9Z8-01A | GALNT3 | chr2 | 166650525 | - | TTC21B | chr2 | 166758420 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-intron | ENST00000392701 | ENST00000489714 | GALNT3 | chr2 | 166650525 | - | TTC21B | chr2 | 166758420 | - |
5UTR-intron | ENST00000392701 | ENST00000536175 | GALNT3 | chr2 | 166650525 | - | TTC21B | chr2 | 166758420 | - |
5UTR-intron | ENST00000392701 | ENST00000243344 | GALNT3 | chr2 | 166650525 | - | TTC21B | chr2 | 166758420 | - |
intron-intron | ENST00000409882 | ENST00000489714 | GALNT3 | chr2 | 166650525 | - | TTC21B | chr2 | 166758420 | - |
intron-intron | ENST00000409882 | ENST00000536175 | GALNT3 | chr2 | 166650525 | - | TTC21B | chr2 | 166758420 | - |
intron-intron | ENST00000409882 | ENST00000243344 | GALNT3 | chr2 | 166650525 | - | TTC21B | chr2 | 166758420 | - |
Top |
FusionProtFeatures for GALNT3_TTC21B |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
GALNT3 | TTC21B |
Catalyzes the initial reaction in O-linkedoligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on theprotein receptor. Has activity toward HIV envelope glycoproteingp120, EA2, Muc2 and Muc5. Probably glycosylates fibronectin invivo. Glycosylates FGF23. Plays a central role in phosphatehomeostasis. {ECO:0000269|PubMed:16638743,ECO:0000269|PubMed:9295285}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for GALNT3_TTC21B |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for GALNT3_TTC21B |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
GALNT3 | APPBP2, MAPK8IP2, RSPRY1 | TTC21B | SPACA1, DOC2A, KRAS, IFT43, TULP3, IFT122, IFT140, WDR19, VCL, WDR35, EIF3L, PRPF31, CCDC40 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for GALNT3_TTC21B |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for GALNT3_TTC21B |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | GALNT3 | C0006663 | Calcinosis | 1 | CTD_human |
Hgene | GALNT3 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | GALNT3 | C0085681 | Hyperphosphatemia (disorder) | 1 | CTD_human |
Tgene | TTC21B | C3151186 | NEPHRONOPHTHISIS 12 | 2 | UNIPROT |
Tgene | TTC21B | C0022658 | Kidney Diseases | 1 | CTD_human |
Tgene | TTC21B | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Tgene | TTC21B | C0265275 | Jeune thoracic dystrophy | 1 | CTD_human;ORPHANET |
Tgene | TTC21B | C2936862 | Bardet-Biedl syndrome 1 (disorder) | 1 | UNIPROT |
Tgene | TTC21B | C3151185 | SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY | 1 | UNIPROT |